Alizyme Report issue

For profit Phase 2 Phase 3
Founded: Cambridge United States (1995)
Status: Defunct (2009)

Organization Overview

First Clinical Trial
2004
NCT00163280
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now